Email Updates


End of AIDS

End of

Learn more

The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:

  • Deliver proven tools for immediate impacts.
  • Demonstrate and roll out new HIV prevention tools.
  • Develop long-term solutions to end the epidemic.

Learn more


  • April 2, 2020

    There’s much we do and don’t know about COVID-19 and the virus that causes it. The global response to COVID-19, which is evolving rapidly, can and must benefit from lessons learned in the fight against HIV. AVAC is committed to data-driven, evidence-based advocacy, and we hope these resources help us all stay up-to-date on the facts, share experiences and make sure interventions for COVID-19 and HIV reach those who need them the most.

  • April 1, 2020

    It is with an incredibly heavy heart that we mourn the passing of Gita Ramjee on Tuesday, March 30 of COVID-19 related complications. She was a great friend to AVAC over the years – and she was an essential partner in helping to navigate the field through more disappointing results than any of us wanted. But those results never deterred her tireless determination to keep pushing for the next trial. Gita will be sorely missed by all of us who had the privilege to work with her. May we all build on her legacy and make her calling, her dream a reality.

  • April 1, 2020

    Many of us are focused on the global—and in most cases very personal—response to the COVID-19 pandemic, but the work in the fight against HIV continues apace. In this update, AVAC shares the essential work of civil society groups and activists who are influencing PEPFAR programming for the coming year. Their continuing advocacy led to important wins, gained over the three weeks spent at the Regional Planning Meetings (RPMs) in Johannesburg.

  • March 10, 2020

    The latest installment of AVAC’s podcast, Px Pulse, is up. In this episode, AVAC puts a spotlight on HVTN 702, or Uhambo, one of the most anticipated HIV vaccine efficacy trials in the field. Data show the vaccine tested is safe, but vaccinations were stopped early after a scheduled review showed it did not offer protection.

Find Resources

AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.

What We Do

AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more

Px Methods

AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.